Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.

Multidrug resistance is a major obstacle to the control of Plasmodium falciparum malaria, and its origins and modes of dissemination are imperfectly understood. In this study, haplotyping and microsatellite analysis of malaria from 5 regions of the South American Amazon support the conclusion that the parasite mutations conferring mid- and high-level resistance to the antifolate combination sulfadoxine-pyrimethamine have a common origin. Parasites harboring these mutations are also found to share drug-resistance alleles that confer a unique chloroquine resistance phenotype and to be similar at loci not linked to drug resistance, although not genetically identical. Since the 1980s, multidrug-resistant P. falciparum has spread in a north-northwest manner across the continent, from an origin likely in the lower Amazon. This study highlights the importance of continent-wide malaria-control policies and suggests that the containment of resistance to the next generation of therapies may be feasible.

[1]  C. Plowe,et al.  Genetics of drug-resistant Plasmodium falciparum malaria in the Venezuelan state of Bolivar. , 2002, The American journal of tropical medicine and hygiene.

[2]  A. Muñoz,et al.  Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. , 2002, American journal of epidemiology.

[3]  P. Roepe,et al.  Evolution of a unique Plasmodium falciparum chloroquine-resistance phenotype in association with pfcrt polymorphism in Papua New Guinea and South America , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  T. Wellems,et al.  Chloroquine-resistant malaria. , 2001, The Journal of infectious diseases.

[5]  M. Tibayrenc,et al.  Evidence for clonal propagation in natural isolates of Plasmodium falciparum from Venezuela , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Wirth,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. , 2000, Memorias do Instituto Oswaldo Cruz.

[7]  D. Roberts,et al.  Malaria in the Americas: a model of reemergence. , 2000, Military medicine.

[8]  J. Wootton,et al.  Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.

[9]  K. Kirk,et al.  Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.

[10]  A. Magill,et al.  The epidemiology of malaria in an epidemic area of the Peruvian Amazon. , 2000, The American journal of tropical medicine and hygiene.

[11]  C. Plowe,et al.  Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. , 1998, Molecular and biochemical parasitology.

[12]  J. Kublin,et al.  Molecular assays for surveillance of antifolate-resistant malaria , 1998, The Lancet.

[13]  O. Doumbo,et al.  Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. , 1997, The Journal of infectious diseases.

[14]  Wiklund Ra,et al.  First of two parts , 1997 .

[15]  X. Su,et al.  Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. , 1996, Genomics.

[16]  R. Paru,et al.  Mating patterns in malaria parasite populations of Papua New Guinea. , 1995, Science.

[17]  L. Ranford-Cartwright,et al.  Proof of intragenic recombination in Plasmodium falciparum. , 1994, Molecular and biochemical parasitology.

[18]  G. Shanks,et al.  Malaria prophylaxis during military operations in Thailand. , 1989, Military medicine.

[19]  M. Levine,et al.  Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries. , 1985, The Journal of infectious diseases.

[20]  G. Cortés,et al.  Sensitivity of Plasmodium falciparum to antimalarial drugs in Colombia. , 1985, The American journal of tropical medicine and hygiene.

[21]  D. Wyler.  Malaria — Resurgence, Resistance, and Research , 1983 .

[22]  B. Albuquerque,et al.  [In vivo resistance of Plasmodium falciparum to the combination of sulfadoxine and pyrimethamine, at RIII level, in Amazonas, Brazil]. , 1982, Revista do Instituto de Medicina Tropical de Sao Paulo.

[23]  J. Hayes,et al.  Drug-resistant falciparum malaria among the Mayongong Indians in the Brazilian Amazon. , 1979, The American journal of tropical medicine and hygiene.

[24]  J. Castro,et al.  Venezuelan strains of Plasmodium falciparum resistant to sulfa and pyrimethamine as demonstrated by in vitro test. , 1977, Revista latinoamericana de microbiologia.

[25]  G. Coatney,et al.  The evaluation of sulfonamides, alone or in combination with pyrimethamine, in the treatment of multi-resistant falciparum malaria. , 1966, The American journal of tropical medicine and hygiene.

[26]  M. D. Young,et al.  CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM PORTO VELHO, BRAZIL. , 1963, The American journal of tropical medicine and hygiene.

[27]  A. Gabaldon,et al.  An attempt to eradicate malaria by the weekly administration of pyrimethamine in areas of out-of-doors transmission in Venezuela. , 1959, The American journal of tropical medicine and hygiene.

[28]  Coatney Gr,et al.  Review of investigations in malaria chemotherapy; (U.S.A.) 1946 to 1954. , 1955 .

[29]  A. Gabaldon,et al.  The first large area in the tropical zone to report malaria eradication: North-Central Venezuela. , 1954, The American journal of tropical medicine and hygiene.

[30]  C. Plowe.  Folate Antagonists and Mechanisms of Resistance , 2001 .

[31]  T. Burkot,et al.  Infectivity to mosquitoes of Plasmodium falciparum clones grown in vitro from the same isolate. , 1984, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  Resistance to Antimalarials.  Chemotherapy of malaria and resistance to antimalarials. Report of a WHO scientific group. , 1973, World Health Organization technical report series.

[33]  A. J. Walker,et al.  Response to drugs of South American strains of Plasmodium falciparum. , 1968, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  J. Lanier,et al.  Observations on two Plasmodium falciparum infections with an abnormal response to chloroquine. , 1961, The American journal of tropical medicine and hygiene.

[35]  M. Pinotti.  A New Method of Malaria Prophylaxis: the Addition of an Antimalarial Drug to Cooking Salt used in the Daily Preparation of Food. , 1954 .